Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Daily News

WHO Endorses Treating Obesity in Adults With GLP-1s

Todd Neale

December 01, 2025

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

Todd Neale

September 18, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Todd Neale

February 26, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Daily News

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Yael L. Maxwell

June 10, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

Advertisement

WHO Endorses Treating Obesity in Adults With GLP-1s

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

May 2025 Dispatch for the CV Team

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

April 2024 Dispatch for the CV Team

TCTMD’s Michael O’Riordan Wins Digital Health Award

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

January 2022 News Roundup

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

February 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content